Pirkko Härkönen - Search Results

Year	Number of Results
2002	4
2003	3
2004	5
2005	8
2006	4
2007	5
2008	7
2009	5
2010	10
2011	1
2012	8
2013	5
2014	4
2015	2
2016	7
2017	2
2018	2
2019	1
2020	1
2021	1
2022	3
2023	1
2024	0

1

Targeting sex steroid biosynthesis for breast and prostate cancer therapy.

Poutanen M, Hagberg Thulin M, Härkönen P. Poutanen M, et al. Among authors: harkonen p. Nat Rev Cancer. 2023 Sep 8. doi: 10.1038/s41568-023-00609-y. Online ahead of print. Nat Rev Cancer. 2023. PMID: 37684402 Review. No abstract available.

2

Tumor models for prostate cancer exemplified by fibroblast growth factor 8-induced tumorigenesis and tumor progression.

Tuomela J, Härkönen P. Tuomela J, et al. Among authors: harkonen p. Reprod Biol. 2014 Mar;14(1):16-24. doi: 10.1016/j.repbio.2014.01.002. Epub 2014 Jan 21. Reprod Biol. 2014. PMID: 24607251 Review.

3

Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.

Härkönen PL, Väänänen HK. Härkönen PL, et al. Ann N Y Acad Sci. 2006 Nov;1089:218-27. doi: 10.1196/annals.1386.045. Ann N Y Acad Sci. 2006. PMID: 17261769 Review.

4

Role of fibroblast growth factor 8 in growth and progression of hormonal cancer.

Mattila MM, Härkönen PL. Mattila MM, et al. Among authors: harkonen pl. Cytokine Growth Factor Rev. 2007 Jun-Aug;18(3-4):257-66. doi: 10.1016/j.cytogfr.2007.04.010. Epub 2007 May 23. Cytokine Growth Factor Rev. 2007. PMID: 17512240 Review.

5

Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum.

Terävä J, Verhassel A, Botti O, Islam MK, Leivo J, Wittfooth S, Härkönen P, Pettersson K, Gidwani K. Terävä J, et al. Among authors: harkonen p. Cancer Rep (Hoboken). 2022 Aug;5(8):e1540. doi: 10.1002/cnr2.1540. Epub 2021 Aug 22. Cancer Rep (Hoboken). 2022. PMID: 34423573 Free PMC article.

6

Editorial comment on: stem cell characteristics in prostate cancer cell lines.

Härkönen P. Härkönen P. Eur Urol. 2010 Feb;57(2):255. doi: 10.1016/j.eururo.2009.01.017. Epub 2009 Jan 19. Eur Urol. 2010. PMID: 19200638 No abstract available.

7

Role of estrogens in development of prostate cancer.

Härkönen PL, Mäkelä SI. Härkönen PL, et al. J Steroid Biochem Mol Biol. 2004 Nov;92(4):297-305. doi: 10.1016/j.jsbmb.2004.10.016. Epub 2004 Dec 19. J Steroid Biochem Mol Biol. 2004. PMID: 15663993 Review.

8

SERMs Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells.

Polari L, Wiklund A, Sousa S, Kangas L, Linnanen T, Härkönen P, Määttä J. Polari L, et al. Among authors: harkonen p. Inflammation. 2018 Aug;41(4):1157-1171. doi: 10.1007/s10753-018-0763-1. Inflammation. 2018. PMID: 29574654 Free PMC article.

9

Editorial comment on: expression and prognostic relevance of annexin A3 in prostate cancer.

Härkönen P. Härkönen P. Eur Urol. 2008 Dec;54(6):1322. doi: 10.1016/j.eururo.2008.01.002. Epub 2008 Jan 16. Eur Urol. 2008. PMID: 18222601 No abstract available.

10

Adenosine inhibits tumor cell invasion via receptor-independent mechanisms.

Virtanen SS, Kukkonen-Macchi A, Vainio M, Elima K, Härkönen PL, Jalkanen S, Yegutkin GG. Virtanen SS, et al. Among authors: harkonen pl. Mol Cancer Res. 2014 Dec;12(12):1863-74. doi: 10.1158/1541-7786.MCR-14-0302-T. Epub 2014 Jul 30. Mol Cancer Res. 2014. PMID: 25080434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year